Tao Zhang
1
Valerie R. Wiersma
2*The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Hematol.
Sec. Blood Cancer
Volume 3 - 2024 |
doi: 10.3389/frhem.2024.1465473
This article is part of the Research Topic Glycobiology in Hematology: a Promising Avenue for Cancer Diagnostics and Therapeutics View all 6 articles
Glycobiology in Hematology, a Promising Avenue for Cancer Diagnostics and Therapeutics
Provisionally accepted- 1 Center for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), Leiden, Netherlands
- 2 Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
Keywords: Hematology, Cancer, Glycosylation, Therapeutic targeting, biomarker
Received: 16 Jul 2024; Accepted: 29 Jul 2024.
Copyright: © 2024 Zhang and Wiersma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Valerie R. Wiersma, Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.